Sensorion Reports Sustained Efficacy in Audiogene Trial and Advances Broad Gene Therapy Pipeline for Hearing Loss
MONTPELLIER, FRANCE – Sensorion, a pioneering clinical-stage biotechnology company dedicated to developing novel therapies for hearing loss disorders, announced significant progress in its gene therapy programs, highlighted by updated six-month…
